A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy

Trial Profile

A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Oliceridine (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Trevena
  • Most Recent Events

    • 17 Oct 2016 According to Trevena media release, the company will webcast and present data at the Annual Meeting of the American Society of Anesthesiologists 2016.
    • 14 May 2016 Results of two phase II studies evaluating early reduction in pain intensity, presented at the 35th Annual Scientific Meeting of the American Pain Society
    • 31 Mar 2016 According to a Trevena media release, the company will present data from this study at 41st Annual Regional Anesthesiology and Acute Pain Medicine Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top